Equity negotiation is one of the most financially consequential and poorly understood dimensions of compensation at technology companies and startups. Most people who receive equity offers — stock options, restricted stock units, or direct equity grants — negotiate them less effectively than they negotiate salary, often because equity feels abstract, conditional, and difficult to value. This cognitive difficulty translates directly into money left on the table, sometimes large amounts of it.
The first thing to understand is what you are actually being offered. The two most common forms of equity compensation for employees are stock options and restricted stock units (RSUs). Stock options give you the right to buy shares at a fixed price (the "strike price" or "exercise price") at some point in the future. If the company's value rises, the option becomes valuable because you can buy at the old price and sell at the new one. If the company's value falls below your strike price, the option is worthless. RSUs are grants of actual shares (or the cash equivalent at vesting) that vest over time — you receive the shares regardless of stock price movement, unlike options, though they are taxable as ordinary income when they vest. At public companies, RSUs are common and their value is calculable because the stock is publicly priced. At private companies and startups, options are more common and their value is profoundly uncertain because there is no public price, the company may never achieve liquidity, and the dilution effects of future financing rounds can significantly erode value.
The four variables that determine option value at a private company: the current estimated fair market value (FMV) of a share (typically set by a 409A valuation), your strike price, how many shares you are being granted, and the company's total capitalization (fully diluted share count, which determines what percentage of the company your grant represents). The percentage is what matters, not the share count — 100,000 shares in a company with 1 billion shares outstanding is 0.01%; 100,000 shares in a company with 10 million shares outstanding is 1%. This arithmetic is simple but requires the data, which candidates must ask for directly. "What is the fully diluted share count?" is a question every equity recipient should ask.
Vesting schedules are the second axis of negotiation. The industry standard is four years with a one-year cliff: you vest nothing for the first year, then 25% on your first anniversary, then the remaining 75% monthly or quarterly over the following three years. This structure serves the employer by requiring extended tenure. Negotiation opportunities exist in the vesting schedule itself: a shorter vesting period, a smaller or eliminated cliff, or accelerated vesting upon a change of control (single-trigger or double-trigger acceleration) all increase the value of the grant by reducing the risk that tenure constraints prevent you from actually receiving it. Double-trigger acceleration — vesting all unvested shares if the company is acquired AND you are terminated — is a particularly valuable provision for senior roles where acquisition typically involves leadership changes.
Refresher grants are the equity dimension most often ignored at offer time. The initial grant vests over four years. After year four, you have received your initial allocation, and unless the company provides refresh grants, your equity exposure ends. At healthy public companies and late-stage startups, annual refresh grants are standard practice. Understanding whether and how the company refreshes equity — at what cadence, based on what criteria — is part of assessing the long-term value of an equity package, not just the initial grant.
At public companies, RSU negotiation is more straightforward. The shares have a real-time price, the value of the grant is calculable, and the question is primarily whether the number of units can be increased or the vesting schedule improved. The leverage available in public company equity negotiation is similar to salary negotiation: market data (public equity grant benchmarks are more available than private company data, especially in tech), competing offers, and clarity about your specific value.
The tax treatment of equity is a separate domain of knowledge that is not part of the negotiation per se but significantly affects the value you actually receive. Incentive stock options (ISOs) have favorable tax treatment if holding period requirements are met; non-qualified stock options (NQOs or NSOs) are taxed as ordinary income at exercise. RSUs are taxed as ordinary income at vesting. Early exercise — buying options when granted rather than waiting for vesting, combined with an 83(b) election — can convert future income tax events into capital gains events, but it requires paying for shares that may be worthless if the company fails. Understanding these tax mechanics is prerequisite to structuring an equity plan that is actually optimal for your situation.
The equity negotiation is ultimately a negotiation about your stake in a future outcome that neither you nor the employer can predict with precision. The discipline required is translating uncertainty into clear-eyed expected value: what is the realistic range of outcomes for this company, how does my grant translate into financial value under each scenario, and what is that worth compared to the cost of accepting a smaller grant or worse terms?